Conference Proceedings
Home
 > 
Browse by Publisher
 > 
BCC Research LLC
 > 
Antiemetics: Technologies and Global Markets

Antiemetics: Technologies and Global Markets

Send a Friend    
Antiemetics: Technologies and Global Markets
Item #: PHM070B
Our Price:   
$2,750.00
Pricing: 
Product Description
Title:Antiemetics: Technologies and Global Markets
Report Code:PHM070B
Pages:115
Format:PDF
Publisher:BCC Research LLC
Published:7/17/2018
Keywords:Global Market for Antiemetics; Market Potential for Antiemetic Drugs; Antiemetic Drugs Industry

Report Scope

The report details the antiemetic drug market. The analysis highlights current and future market potential for antiemetic drug and presents a detailed review of pipeline drugs, blockbuster drugs, and challenges to market growth. The report also examines disease burden, regulatory environment, novel technologies, and market projections to 2023. Antiemetic drug market drivers, trends and potential regional market opportunities are also covered in this report.

The report details market shares of antiemetic drug class (5-HT3 receptor antagonists, dopamine antagonists, steroid-corticosteroids, benzodiazepines, NK1 receptor antagonist, antihistamines, cannabinoids, and anticholinergic) and geographic market segmentation of overall market; global market share by applications, with special emphasis on developed and underdeveloped geographic regions. For market estimates, data has been provided for 2017, as base year, 2018 and forecast for 2023.

Report Includes

- 21 data tables and 15 additional tables
- Country specific data and analysis for United States, Canada, Mexico, France, Germany, UK, China, India, Japan, and Middle East and Africa
- An overview about current and future market potential for antiemetic drugs with special focus on competitive environment, pipeline drugs and blockbuster drugs
- Coverage of disease burden, regulatory environment, and novel technologies in the antiemetic drugs market
- Detailed description about vestibular disorder and increasing demand of innovative technology for treatment
- Exploration of the causes of emesis, usage of antiemetics and the types of products available to treat nausea and vomiting by each application segment
- Information about the launching of new drugs in each antiemetic drug class such as 5 HT3 receptor antagonists, dopamine antagonists, NK1 receptor antagonist, and so forth
- Detailed company profiles of major players in the market, including Abbott Laboratories, Daiichi Sankyo Company, Ltd., Merck & Co., Novartis AG, Sanofi Aventis and Teva Pharmaceutical Industries Ltd.

Related Products
Browse By PublisherShop By Category
Dave A Curran, EzineArticles.com Basic Author